Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Department of Health and Human Services
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treat
Funding
Award size
$100K – $1M
Award ceiling
200000
Type
Grant
Dates
Deadline
Later
Posted
12/02/2024
Closes
2027-11-16
Eligibility
Eligibility
Small businessesFor profit organizations other than small businessesState governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationCounty governmentsNative American tribal organizations (other than Federally recognized tribal governments)Independent school districtsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Special district governmentsNative American tribal governments (Federally recognized)Public and State controlled institutions of higher educationCity or township governmentsPublic housing authorities/Indian housing authorities
Program
Funding area
Health - HLIncome Security and Social Services - ISS
Opportunity #
PAR-25-266
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov